Cullinan Oncology LLC
Biotechnology
Healthcare
CGEM
59.02 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
6.30
52 week high
18.25
high
6.40
52 week low
0.00
previous Close
6.28
P/E ratio
-6
market cap
429 M
div yield
0
net incoming
-70.06 M
-44.44 %
net profit margin
-7005500000.00 %
0.00 %
operating incoming
-75.80 M
-37.82 %
net change in cash
-3.84 M
39.61 %
cash on hand
72.82 M
-5.00 %
cost of revenue
77.00 K
0.00 %
top